Press release
Exocrine Pancreatic Insufficiency (EPI) Market CAGR of around 5.9%
Exocrine Pancreatic Insufficiency (EPI) Market
The Exocrine Pancreatic Insufficiency (EPI) Market was valued at USD 3.4 billion in 2024 and is projected to reach USD 5.8 billion by 2034, growing at a CAGR of around 5.9%. Growth is driven by increasing prevalence of chronic pancreatitis, cystic fibrosis, and other digestive disorders, along with rising demand for pancreatic enzyme replacement therapies (PERT).
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71138
Key Market Drivers
• Growing incidence of EPI from chronic pancreatitis and cystic fibrosis.
• Rising adoption of pancreatic enzyme replacement therapy (PERT) to improve digestion and nutrient absorption.
• Advancements in diagnostic tools like fecal elastase testing improving early detection.
• Increasing healthcare awareness and expanded gastroenterology care networks.
Challenges
• Long-term therapy adherence concerns.
• High cost of enzyme replacement products.
• Underdiagnosis in some regions due to nonspecific symptoms.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71138/exocrine-pancreatic-insufficiency-market
Market Segmentation
By Treatment
• Pancreatic enzyme replacement therapy (PERT)
• Acid suppressants (PPIs/H2 blockers, adjunctive)
• Nutritional supplements
By Diagnosis
• Fecal elastase testing
• Serum tests (amylase/lipase)
• Imaging (MRI/CT/ultrasound)
• Breath tests
By End User
• Hospitals
• Gastroenterology clinics
• Specialty digestive disorder centers
• Homecare settings
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71138
Regional Snapshot
• North America leads due to high diagnostic rates, strong PERT uptake, and advanced GI care access.
• Europe shows steady growth backed by structured digestive disease management.
• Asia-Pacific is the fastest-growing region with rising awareness and expanding healthcare infrastructure.
Key Companies
AbbVie, Takeda, Allergan, Mylan, Nestlé Health Science, Sanofi, GSK (nutritional divisions), Fresenius Kabi.
Future Outlook
The EPI market will continue expanding with enhanced enzyme formulations, wider use of combination therapies, and improved early diagnosis. Growth in chronic pancreatitis and cystic fibrosis treatment programs, along with digital health management tools, will further support long-term market adoption.
This report is also available in the following languages : Japanese (膵外分泌機能不全市場), Korean (외분비 췌장 부전 시장), Chinese (外分泌性胰腺功能不全市场), French (Marché de l'insuffisance pancréatique exocrine), German (Markt für exokrine Pankreasinsuffizienz), and Italian (Mercato dell'insufficienza pancreatica esocrina), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71138
Our More Reports:
Nasal Polyposis Market
https://exactitudeconsultancy.com/reports/70749/nasal-polyposis-market
Chronic Otitis Media Market
https://exactitudeconsultancy.com/reports/70751/chronic-otitis-media-market
Otitis Media Market
https://exactitudeconsultancy.com/reports/70753/otitis-media-market
Rhinosinusitis Market
https://exactitudeconsultancy.com/reports/70755/rhinosinusitis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Market CAGR of around 5.9% here
News-ID: 4311740 • Views: …
More Releases from Exactitude Consultancy
Eosinophilic Gastroenteritis Market is valued at around USD 160 million in 2024 …
Eosinophilic Gastroenteritis Market
The Eosinophilic Gastroenteritis (EGE) Market is valued at around USD 160 million in 2024 and is projected to reach approximately USD 290 million by 2034, registering a CAGR of about 6.1%. Growth is supported by increasing diagnosis rates, expanding awareness of eosinophilic gastrointestinal disorders, and improved imaging and biopsy-based testing.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71136
Key Market Drivers
• Increasing incidence of allergic and immune-mediated gastrointestinal conditions.
• Greater…
Body Contouring Devices Market is projected to reach USD 16.04 billion by 2034
The global Body Contouring Devices Market was valued at USD 7.28 billion in 2024 and is projected to reach USD 16.04 billion by 2034, growing at a CAGR of 8.3% during 2025-2034. Growth is driven by rising demand for minimally invasive cosmetic procedures, growing global obesity rates, increasing aesthetic awareness, and expanding medical spa and dermatology clinic networks.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70968
Body contouring devices are…
Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 20 …
Chronic Idiopathic Constipation (CIC) Market
The Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.9 billion by 2034, growing at a CAGR of around 4.8%. Growth is driven by rising gastrointestinal disorders, aging population, lifestyle factors, and wider adoption of prescription CIC therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71132
Key Market Drivers
• Increasing prevalence of lifestyle-related constipation and sedentary…
Symptomatic Partial-Thickness Rotator Cuff Tears Market is projected to reach US …
The global Symptomatic Partial-Thickness Rotator Cuff Tears (PTRCT) Market was valued at USD 1.64 billion in 2024 and is projected to reach USD 2.95 billion by 2034, growing at a CAGR of 6.1% during 2025-2034. Market expansion is driven by rising sports injuries, increasing prevalence of degenerative shoulder conditions in aging populations, advancements in minimally invasive arthroscopy, and growing adoption of regenerative biologics such as PRP and stem-cell therapies.
Download Full…
More Releases for EPI
Emerging Trends to Reshape the Silicon EPI Wafer Market: Next-Generation Silicon …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Silicon EPI Wafer Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the silicon epi wafer has experienced consistent expansion in the previous years, seeing a projected rise from a value of $1.8 billion in 2024 to $1.89 billion in 2025. This…
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
